市場調査レポート

遺伝子検査市場および予測:世界市場分析(2010〜2015年)

Genetic Testing Market and Forecast - Global Analysis 2010-2015

発行 Renub Research 商品コード 223412
出版日 ページ情報 英文 57 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
遺伝子検査市場および予測:世界市場分析(2010〜2015年) Genetic Testing Market and Forecast - Global Analysis 2010-2015
出版日: 2011年11月14日 ページ情報: 英文 57 Pages
概要

遺伝子検査市場は世界的にCAGR18%で拡大しており、2015年までには100億米ドル規模になると予測されています。遺伝子疾患発症率の増加と分子診断需要の増大、高齢化、慢性疾患の増加などが主な理由となっています。

当レポートでは、遺伝子検査市場の過去と現在、将来的見通しについて調査し、5つの応用分野別の動向、今後市場が直面する課題、市場に参入する主な企業の概要などをまとめ、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 世界の遺伝子検査市場

第3章 遺伝子検査市場シェアと将来予測

第4章 遺伝子検査市場(応用別):2005〜2015年

  • 癌遺伝子検査市場
  • 出生前遺伝子検査市場
  • 素因遺伝子検査市場
  • ファーマコゲノミクス遺伝子検査市場

第5章 企業の発展

  • LabCorpがGenzymeの遺伝子検査部門を買収
  • DNA Testing SystemsがDNAPrint Genomics Incとの契約に署名
  • HologicがThird Wave Technologiesを買収
  • PerkinElmerがNewborn Metabolic Screening Assets of Pediatrixを買収
  • AffymetrixがPanomicsを買収

第6章 試験所の合併・買収

第7章 遺伝子検査の促進因子

  • 遺伝子検査市場の現状と将来
  • 癌発症率上昇
  • 将来的に市場を促進する新興経済国
  • 検査の利用可能性の拡大によって診断すべき患者が増加
  • 消費者への直接検査の利用可能性が検査件数を増大させる

第8章 遺伝子検査の課題

  • 検査と検査試験所の品質を保証するための監視制度の不備
  • 遺伝子検査実施のための専門的ガイドラインの不備

第9章 企業分析

  • Orchid Cellmark Inc
  • 23andMe
  • Pathway Genomics Corporation
  • Navigenics
  • deCODE Genetics
    • 強み
    • 弱み

図表

目次

Abstract

Genetic Testing - Market Overview

The genetic testing market is witnessing a period of profound growth. Growing with a CAGR of 18 percent globally genetic testing market is expected to cross the figure of US$ 10 Billion by 2015. This significant growth is primarily attributed to the incidence of genetic diseases, burgeoning demand for molecular diagnostics, aging population, and subsequent increase in chronic diseases. Increasing knowledge about the potential benefits in genetic testing has been one of the prime reasons for the growth in genetic testing.

Pharmacogenomics is the most lucrative segment of genetic testing. Cancer genetic testing should post strong position in the genetic testing industry due to rising cases of cancer patients with the market share of around 23% in 2010 and it is expected that cancer genetic testing will lead the genetic testing market by 2015. The future growth in genetic testing is expected to come from prenatal and predisposition genetic testing.

Genetic testing is becoming an integral and growing part of healthcare provision and services. Advancements in genetic testing, together with genetically engineered drugs, are expected to aid in tailoring personalized medicine for specific races, individuals, and families. The genetic testing sector will grow rapidly over the next 5 to 10 years and spread beyond the small number of specialist genetic centres.

Report Details

" Genetic Testing Market & Future Forecast - Global Analysis 2010 - 2015" report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:

  • Global Genetic Testing Market (2005 - 2015)
  • Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data of Past, Present and Future Market
  • United States immigration genetic testing market
  • Top Corporate past, present developments
  • Top Laboratory Merger & Acquisition deals from 2007 - 2009
  • Driving forces for the growth of global genetic testing market
  • Challenges faced by genetic testing market in the coming years
  • Key Players analysis in the genetic testing market

Research Highlights

  • Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by 2015
  • Cancer Genetic testing dominates the Genetic Testing market with more than 35% market share by 2015
  • Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the genetic testing market.
  • Prenatal & Predisposition genetic testing will have a combined market share of 26% by 2015

Company Analysis

This section covers the key facts about the major companies that play an important role in Genetic Testing Market. The companies analyzed in this section are - Orchid Cellmark Inc, 23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies have been analyzed from two points of view 1) Strength of the company in genetic testing market 2) Weakness of the company in genetic testing market.

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Table of Contents

1. Executive Summary

2. Global Genetic Testing Market

3. Genetic Testing Market Share & Future Forecast

4. Genetic Testing Market (Application Segment) 2005 - 2015

  • 4.1 Cancer Genetic Testing Market
  • 4.2 Prenatal Genetic Testing Market
  • 4.3 Predisposition Genetic Testing Market
  • 4.4 Pharmacogenomics Genetic Testing Market

5. Corporate Developments

  • 5.1 LabCorp to Buy Genzyme's Genetic Testing Unit
  • 5.2 DNA Testing Systems Inks Agreement with DNAPrint Genomics Inc.
  • 5.3 Hologic to Acquire Third Wave Technologies
  • 5.4 PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix
  • 5.5 Affymetrix to Acquire Panomics

6. Laboratory Merger & Acquisition

7. Driving Forces for Genetic Testing

  • 7.1 Present Development and Future of Genetic Testing Market
  • 7.2 Increased Incidence of Cancer
  • 7.3 Emerging Economies is Expected to Drive the Market in Future
  • 7.4 Increasing Availability of Tests Allows More Patients to be Diagnosed
  • 7.5 Availability of Direct-to-Consumer Tests to Increase Test Volumes

8. Challenges for Genetic Testing

  • 8.1 Lack of a Coherent Oversight System to Ensure the Quality of Tests and Testing Laboratories
  • 8.2 Dearth of Professional Guidelines for Conducting Genetic Tests

9. Companies Analysis

  • 9.1 Orchid Cellmark Inc
    • 9.1.1 Strengths
    • 9.1.2 Weaknesses
  • 9.2 23andMe
    • 9.2.1 Strengths
    • 9.2.2 Weaknesses
  • 9.3 Pathway Genomics Corporation
    • 9.3.1 Strengths
    • 9.3.2 Weaknesses
  • 9.4 Navigenics
    • 9.4.1 Strengths
    • 9.4.2 Weaknesses
  • 9.5 deCODE Genetics
    • 9.5.1 Strengths
    • 9.5.2 Weaknesses

List of Figures:

  • Figure 2 1: Global - Genetic Testing Market (Million US$), 2005 - 2010
  • Figure 2 2: Global - Forecast for Genetic Testing Market (Million US$), 2011 - 2015
  • Figure 3 1: Global - Genetic Testing Market Share (Percent), 2008 - 2010
  • Figure 3 2: Global - Forecast for Genetic Testing Market Share (Percent), 2011 - 2015
  • Figure 4 1: Global - Cancer Genetic Testing Market (Million US$), 2000 - 2010
  • Figure 4 2: Global - Forecast for Cancer Genetic Testing Market (Million US$), 2011 - 2015
  • Figure 4 3: Global - Prenatal Genetic Testing Market (Million US$), 2000 - 2010
  • Figure 4 4: Global - Forecast for Prenatal Genetic Testing Market (Million US$), 2011 - 2015
  • Figure 4 5: Global - Predisposition Genetic Testing Market (Million US$), 2000 - 2010
  • Figure 4 6: Global - Forecast for Predisposition Genetic Testing Market (Million US$), 2011 - 2015
  • Figure 4 7: Global - Pharmacogenomics Genetic Testing Market (Million US$), 2005 - 2010
  • Figure 4 8: Global - Forecast for Pharmacogenomics Genetic Testing Market (Million US$), 2011 - 2015
  • Figure 5 1: United States - Immigration Testing Market (Million US$), 2007 - 2010
  • Figure 5 2: United States - Forecast for Immigration Testing Market (Million US$), 2011 - 2015
  • Figure 8 1: BRIC - In Vitro Diagnostic Market (Billion US$), 2009 - 2010
  • Figure 8 2: BRIC - Forecast for In Vitro Diagnostic Market (Billion US$), 2011 - 2015
  • Figure 8 3: Global - Growth of Laboratory Directory (Number), 2000 - 2010
  • Figure 8 5: Global - Direct to Consumer Genetic Testing Market (Million US$), 2008 - 2010
  • Figure 8 6: Global - Forecast for Direct to Consumer Genetic Testing Market (Million US$), 2011 - 2015
  • Figure 10 1: Orchid Cellmark Inc Laboratories - Key Financials (Million US$) 2007 - 2009

List of Tables:

  • Table 6 1: LabCorp & Genzyme Genetic - Acquisitions (Million US$), 2010
  • Table 6 2: Hologic & Third Wave Technologies - Acquisitions (Million US$), 2008
  • Table 6 3: PerkinElmer Inc & Pediatrix Medical Group - Acquisitions 2008
  • Table 6 4: Affymetrix & Panomics - Acquisitions (Million US$), 2008
  • Table 7 1: Global - Laboratory Merger & Acquisition (Million US$), January 2007 - July 2009
  • Table 8 1: Global - New Cancer Cases & Deaths & Forecast (Million), 2000 & 2020
  • Table 8 2: Global - All Cancers (excluding non-melanoma Skin Cancer) Incidence and Mortality (Thousand), 2008
Back to Top